Crimson is a private pharmaceutical company that acquires, develops and commercializes innovative therapeutics to address unmet medical and economic needs in the Asian market. Crimson focuses on acquiring the regional rights to pharmaceutical compounds and technologies with significant pre-clinical, clinical or market data, and adds value by accelerating their time-to-market through efficient clinical and regulatory development in China.Founded in 2002, Crimson is headquartered in Hong Kong and also operates in the United States and China.